We also chose these cell lines because NSMCE2 and MAL2 are amplified in all except in MDAMB231 (visualized using cBioPortal on data from the Cell Line Encyclopedia [26], Fig. S3A), which recapitulates our observation in breast cancer patients’ datasets where these two genes were frequently amplified. This evidence concerns the gene MAL2 and breast cancer.